Redmile Group, LLC 13D and 13G filings for Immunome, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 4:15 pm Purchase | 2025-12-31 | 13G | IMMUNOME INC IMNM | Redmile Group, LLC | 5,718,385 5.200% | 357,198 (+6.66%) | Filing |
| 2025-05-15 9:01 pm Purchase | 2025-03-31 | 13G | IMMUNOME INC IMNM | Redmile Group, LLC | 5,361,187 6.200% | 471,633 (+9.65%) | Filing |
| 2024-11-14 9:00 pm Purchase | 2024-09-30 | 13G | IMMUNOME INC IMNM | Redmile Group, LLC | 4,889,554 8.100% | 1,010,139 (+26.04%) | Filing |
| 2023-10-12 5:15 pm Purchase | 2023-10-02 | 13G | IMMUNOME INC IMNM | Redmile Group, LLC | 3,879,415 9.100% | 3,879,415 (New Position) | Filing |